Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Riedel Norbert G
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   854,950    

Indirect Shares

  740,608      
Direct Value   $5,754,680    

Indirect Value

  $71,098      
Total Shares   1,595,558      
Total Value   $5,825,778      


Baxter International Inc
 $2,320,281 Oscient Pharmaceuticals Corp
 $0 Ariad Pharmaceuticals Inc
 $0 Jazz Pharmaceuticals Inc
 $1,497,545 Aptinyx Inc.
 $59,065 Cerevel Therapeutics Holdings, Inc.
 $1,877,788 Baxter International Inc
 $2,320,281 Oscient Pharmaceuticals Corp
 $0 Ariad Pharmaceuticals Inc
 $0 Jazz Pharmaceuticals Inc
 $1,497,545 Aptinyx Inc.
 $59,065 Cerevel Therapeutics Holdings, Inc.
 $1,877,788
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    2   
    0    

     Stock price went up :

    1   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -38.2%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Baxter International Inc BAX Corporate Vice President 2013-01-16 56,689 2005-03-14 0    Premium*  
            Oscient Pharmaceuticals Corp OSCIQ Director 2008-06-12 1,340 2006-06-08 0    Premium*  
            Ariad Pharmaceuticals Inc ARIA Director 2016-02-01 121,859 2011-04-28 0    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 13,705 2013-05-09 0    Premium*  
            Aptinyx Inc. APTX 2021-12-06 615,265 2021-12-06 740,608    Premium*  
            Cerevel Therapeutics Holdings, I... CERE Director 2023-06-07 46,092 0    Premium*  
* Premium Members only  

Records found :    75         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2022-08-08 4 S $152.32 $165,877 D/D (1,089) 11,871 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2022-08-05 4 A $0.00 $0 D/D 2,561 12,960 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2023-08-14 4 S $138.16 $171,454 D/D (1,241) 13,705 0 -
CERE Cerevel Therapeutics Hold... Director   –       •      –    2020-10-27 3 IO $0.00 $0 D/D 0 14,270 %
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2023-08-11 4 A $0.00 $0 D/D 3,075 14,946 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2022-08-05 4 OE $55.28 $442,240 D/D 8,000 18,399 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2005-03-14 4 A $0.00 $0 D/D 12,000 27,247 -
CERE Cerevel Therapeutics Hold... Director   –       •      –    2021-01-04 4 OE $0.00 $0 D/D 14,270 28,540 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2007-03-14 4 D $50.74 $111,070 D/D (2,189) 34,618 0 -
APTX Aptinyx Inc. CEO and President   •       •      –    2020-01-10 4 B $3.00 $105,000 I/I 35,000 35,000 2.66 %
BAX Baxter International Inc Corporate Vice President   •       –      –    2009-03-16 4 D $51.07 $107,502 D/D (2,105) 36,143 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2009-12-02 4 S $55.92 $5,172,600 D/D (92,500) 36,424 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2006-03-14 4 D $38.35 $45,521 D/D (1,187) 36,807 -
ARIA Ariad Pharmaceuticals Inc Director   –       •      –    2011-05-02 3 IO $0.00 $0 D/D 0 37,000 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2008-03-15 4 D $55.41 $31,584 D/D (570) 37,799 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2006-03-14 4 A $0.00 $0 D/D 10,200 37,994 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2009-01-26 4 S $58.00 $1,293,400 D/D (22,300) 38,099 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2009-01-27 4 S $58.09 $4,647,200 D/D (80,000) 38,099 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2008-03-14 4 D $56.27 $122,669 D/D (2,180) 38,369 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2007-03-15 4 A $0.00 $0 D/D 5,800 40,418 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2007-06-05 4 S $57.50 $3,138,885 D/D (54,584) 40,418 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2007-06-06 4 S $57.40 $2,278,780 D/D (39,700) 40,418 0 -
CERE Cerevel Therapeutics Hold... Director   –       •      –    2022-01-04 4 OE $0.00 $0 D/D 14,270 42,810 0 -
CERE Cerevel Therapeutics Hold... Director   –       •      –    2023-06-07 4 A $0.00 $0 D/D 3,282 46,092 0 -
BAX Baxter International Inc Corporate Vice President   •       –      –    2010-03-15 4 D $58.37 $44,536 D/D (763) 49,485 0 -

  75  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed